Literature DB >> 20676705

Generation of transgenic mice for conditional overexpression of Sox9.

Youngwoo Kim1, Hiroki Murao, Koji Yamamoto, Jian Min Deng, Richard R Behringer, Takashi Nakamura, Haruhiko Akiyama.   

Abstract

Sox9 belongs to the family of Sry-related high-mobility group box transcription factors controlling cell fate, cell proliferation and differentiation in various tissues, including cartilage, testis, the central nervous system, kidney, and gastrointestine. Mice conditionally lacking Sox9 have revealed essential roles for Sox9 in these tissues. To gain further insight into the role of Sox9 in different tissues and at different stages of development, we have generated a transgenic mouse line to express Sox9 in a Cre recombinase-dependent manner. The construct contained the human cytomegalovirus enhancer and chicken β-actin promoter, and a floxed monomeric red fluorescence protein 1 (mRFP1) cassette to direct ubiquitous expression of mRFP1. Cre expression removed the mRFP1 gene, allowing expression of Sox9 and enhanced green fluorescent protein. Expectedly, overexpression of Sox9 in chondrocytes using Col2a1-Cre mice suppressed chondrocyte hypertrophy, and delayed terminal differentiation and subsequent ossification. Misexpression of Sox9 in hypertrophic chondrocytes using Col10a1-Cre knock-in mice also delayed terminal differentiation. This Sox9 conditional transgenic mouse line will be a valuable tool to uncover tissue-specific and developmental stage-specific functions of Sox9.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676705      PMCID: PMC3977853          DOI: 10.1007/s00774-010-0206-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  17 in total

1.  A monomeric red fluorescent protein.

Authors:  Robert E Campbell; Oded Tour; Amy E Palmer; Paul A Steinbach; Geoffrey S Baird; David A Zacharias; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

2.  Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa.

Authors:  Haruhiko Akiyama; Marie-Christine Chaboissier; Richard R Behringer; David H Rowitch; Andreas Schedl; Jonathan A Epstein; Benoit de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

3.  Dominance of SOX9 function over RUNX2 during skeletogenesis.

Authors:  Guang Zhou; Qiping Zheng; Feyza Engin; Elda Munivez; Yuqing Chen; Eiman Sebald; Deborah Krakow; Brendan Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

4.  Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors.

Authors:  Haruhiko Akiyama; Jung-Eun Kim; Kazuhisa Nakashima; Gener Balmes; Naomi Iwai; Jian Min Deng; Zhaoping Zhang; James F Martin; Richard R Behringer; Takashi Nakamura; Benoit de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

5.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.

Authors:  Haruhiko Akiyama; Marie-Christine Chaboissier; James F Martin; Andreas Schedl; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

6.  Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment.

Authors:  Valerie P I Vidal; Marie-Christine Chaboissier; Susanne Lützkendorf; George Cotsarelis; Pleasantine Mill; Chi-Chung Hui; Nicolas Ortonne; Jean-Paul Ortonne; Andreas Schedl
Journal:  Curr Biol       Date:  2005-08-09       Impact factor: 10.834

7.  Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells.

Authors:  B P Zambrowicz; A Imamoto; S Fiering; L A Herzenberg; W G Kerr; P Soriano
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

8.  Interactions between Sox9 and beta-catenin control chondrocyte differentiation.

Authors:  Haruhiko Akiyama; Jon P Lyons; Yuko Mori-Akiyama; Xiaohong Yang; Ren Zhang; Zhaoping Zhang; Jian Min Deng; Makoto M Taketo; Takashi Nakamura; Richard R Behringer; Pierre D McCrea; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2004-05-01       Impact factor: 11.361

9.  Functional analysis of Sox8 and Sox9 during sex determination in the mouse.

Authors:  Marie-Christine Chaboissier; Akio Kobayashi; Valerie I P Vidal; Susanne Lützkendorf; Henk J G van de Kant; Michael Wegner; Dirk G de Rooij; Richard R Behringer; Andreas Schedl
Journal:  Development       Date:  2004-03-31       Impact factor: 6.868

10.  Exogenous retinoic acid rapidly induces anterior ectopic expression of murine Hox-2 genes in vivo.

Authors:  R A Conlon; J Rossant
Journal:  Development       Date:  1992-10       Impact factor: 6.868

View more
  28 in total

1.  BMP-Smad4 signaling is required for precartilaginous mesenchymal condensation independent of Sox9 in the mouse.

Authors:  Joohyun Lim; Xiaolin Tu; Kyunghee Choi; Haruhiko Akiyama; Yuji Mishina; Fanxin Long
Journal:  Dev Biol       Date:  2015-01-29       Impact factor: 3.582

2.  Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.

Authors:  Joshua M Adams; Kari A Huppert; Eumenia C Castro; Mario F Lopez; Nima Niknejad; Sanjay Subramanian; Neda Zarrin-Khameh; Milton J Finegold; Stacey S Huppert; Hamed Jafar-Nejad
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.425

Review 3.  Achondroplasia: Development, pathogenesis, and therapy.

Authors:  David M Ornitz; Laurence Legeai-Mallet
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

4.  Putative function of TAP63α during endochondral bone formation.

Authors:  Feifei Li; Yaojuan Lu; Ming Ding; Guojun Wu; Satrajit Sinha; Siying Wang; Qiping Zheng
Journal:  Gene       Date:  2012-01-05       Impact factor: 3.688

5.  Persistent Sox9 expression in hypertrophic chondrocytes suppresses transdifferentiation into osteoblasts.

Authors:  Julian C Lui; Shanna Yue; Audrey Lee; Bijal Kikani; Adrian Temnycky; Kevin M Barnes; Jeffrey Baron
Journal:  Bone       Date:  2019-05-20       Impact factor: 4.398

6.  Mutant activated FGFR3 impairs endochondral bone growth by preventing SOX9 downregulation in differentiating chondrocytes.

Authors:  Zi-Qiang Zhou; Sara Ota; Chuxia Deng; Haruhiko Akiyama; Peter J Hurlin
Journal:  Hum Mol Genet       Date:  2014-11-28       Impact factor: 6.150

Review 7.  Toward regeneration of articular cartilage.

Authors:  Masahiro Iwamoto; Yoichi Ohta; Colleen Larmour; Motomi Enomoto-Iwamoto
Journal:  Birth Defects Res C Embryo Today       Date:  2013-09

8.  Sox9 overexpression in uterine epithelia induces endometrial gland hyperplasia.

Authors:  Gabriel Gonzalez; Shyamin Mehra; Ying Wang; Haruhiko Akiyama; Richard R Behringer
Journal:  Differentiation       Date:  2016-06-01       Impact factor: 3.880

9.  Targeted and sustained Sox9 expression in mouse hypertrophic chondrocytes causes severe and spontaneous osteoarthritis by perturbing cartilage homeostasis.

Authors:  Bojian Liang; Murali K Mamidi; William E Samsa; Yuqing Chen; Brendan Lee; Qiping Zheng; Guang Zhou
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

10.  Dynamic epigenetic mechanisms regulate age-dependent SOX9 expression in mouse articular cartilage.

Authors:  Mingcai Zhang; Qinghua Lu; Andrew H Miller; Nicholas C Barnthouse; Jinxi Wang
Journal:  Int J Biochem Cell Biol       Date:  2016-01-20       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.